Sanpower's SVP Says Dendreon Deal Is a Milestone

SunPower has acquired Dendreon, marking the first acquisition of innovative US products by a Chinese company. The deal, valued at $820 million, is part of SunPower's strategy to expand into healthcare. Despite paying a premium compared to Valiant's previous purchase, SunPower believes the price is justified due to Dendreon's turnaround and profitability. The acquisition aligns with SunPower's plans to launch products in China and other markets.

What makes the acquisition of Dendreon by SunPower significant?

• It is the first acquisition by a Chinese company in the U.S. healthcare market.

• It is the largest acquisition in the history of SunPower.

• It is the first acquisition involving a cash payment.

• It involves the acquisition of a bankrupt company.

How much did SunPower pay in cash for Dendreon?

• $1 billion

• $495 million

• $820 million

• $150 million

What was the premium percentage paid by SunPower compared to Valiant's acquisition?

• 50%

• 75%

• 100%

• 150%

What was the financial state of Dendreon at the time of Valiant's acquisition?

• Profitable and expanding

• Bankrupt with many problems

• Stable with moderate growth

• Newly established with potential

What is the forecasted sales figure for Dendreon in the second half according to Valiant's press release?

• $65 million

• $130 million

• $820 million

• $495 million